News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,813 Results
Type
Article (43492)
Company Profile (248)
Press Release (669073)
Multimedia
Podcasts (54)
Webinars (12)
Section
Business (206519)
Career Advice (2142)
Deals (35755)
Drug Delivery (107)
Drug Development (82575)
Employer Resources (174)
FDA (16387)
Job Trends (15147)
News (349980)
Policy (33192)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2650)
Accelerated approval (5)
Adcomms (21)
Allergies (85)
Alliances (50013)
ALS (91)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (116)
Approvals (16384)
Artificial intelligence (241)
Autoimmune disease (21)
Automation (15)
Bankruptcy (365)
Best Places to Work (11856)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (176)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (263)
Cancer (2104)
Cardiovascular disease (172)
Career advice (1783)
Career pathing (29)
CAR-T (149)
Cell therapy (416)
Cervical cancer (20)
Clinical research (66968)
Collaboration (798)
Compensation (508)
Complete response letters (21)
COVID-19 (2645)
CRISPR (38)
C-suite (226)
Cystic fibrosis (101)
Data (2064)
Decentralized trials (2)
Denatured (17)
Depression (43)
Diabetes (261)
Diagnostics (6443)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (110)
Drug shortages (26)
Duchenne muscular dystrophy (93)
Earnings (86712)
Editorial (39)
Employer branding (22)
Employer resources (148)
Events (114736)
Executive appointments (699)
FDA (17579)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (725)
Gene editing (103)
Generative AI (19)
Gene therapy (294)
GLP-1 (727)
Government (4544)
Grass and pollen (4)
Guidances (51)
Healthcare (19302)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (26)
Infectious disease (2788)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (92)
Interviews (328)
IPO (16612)
IRA (43)
Job creations (3706)
Job search strategy (1522)
Kidney cancer (9)
Labor market (36)
Layoffs (469)
Leadership (16)
Legal (8060)
Liver cancer (72)
Lung cancer (303)
Lymphoma (140)
Machine learning (5)
Management (59)
Manufacturing (291)
MASH (63)
Medical device (13508)
Medtech (13513)
Mergers & acquisitions (19659)
Metabolic disorders (673)
Multiple sclerosis (76)
NASH (16)
Neurodegenerative disease (86)
Neuropsychiatric disorders (25)
Neuroscience (1899)
NextGen: Class of 2025 (6732)
Non-profit (4694)
Northern California (2542)
Now hiring (38)
Obesity (364)
Opinion (215)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (80)
Parkinson's disease (148)
Partnered (21)
Patents (222)
Patient recruitment (100)
Peanut (48)
People (58238)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20812)
Phase II (29441)
Phase III (21993)
Pipeline (1121)
Policy (142)
Postmarket research (2703)
Preclinical (8883)
Press Release (65)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (251)
Rare diseases (380)
Real estate (6043)
Recruiting (65)
Regulatory (22610)
Reports (46)
Research institute (2385)
Resumes & cover letters (369)
Rett syndrome (4)
RNA editing (4)
RSV (43)
Schizophrenia (66)
Series A (127)
Series B (82)
Service/supplier (11)
Sickle cell disease (55)
Southern California (2185)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (28)
Startups (3610)
State (2)
Stomach cancer (14)
Supply chain (66)
Tariffs (25)
The Weekly (35)
United States (22152)
Vaccines (685)
Venture capitalists (38)
Weight loss (239)
Women's health (34)
Worklife (16)
Date
Last 7 days (476)
Last 30 days (2182)
Last 365 days (33096)
2025 (9289)
2024 (35573)
2023 (40467)
2022 (51607)
2021 (56205)
2020 (54845)
2019 (47590)
2018 (35815)
2017 (32635)
2016 (32251)
2015 (38297)
2014 (32051)
2013 (27197)
2012 (29458)
2011 (30147)
2010 (28495)
Location
Africa (756)
Alabama (52)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38566)
Australia (6363)
California (5795)
Canada (1949)
China (498)
Colorado (254)
Connecticut (262)
Delaware (134)
Europe (83405)
Florida (862)
Georgia (204)
Idaho (58)
Illinois (526)
India (25)
Indiana (301)
Iowa (9)
Japan (150)
Kansas (104)
Kentucky (24)
Louisiana (9)
Maine (62)
Maryland (865)
Massachusetts (4375)
Michigan (219)
Minnesota (380)
Mississippi (2)
Missouri (80)
Montana (28)
Nebraska (25)
Nevada (60)
New Hampshire (64)
New Jersey (1670)
New Mexico (29)
New York (1659)
North Carolina (946)
North Dakota (7)
Northern California (2542)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1308)
Puerto Rico (11)
Rhode Island (31)
South America (1188)
South Carolina (20)
South Dakota (1)
Southern California (2185)
Tennessee (101)
Texas (864)
Utah (173)
Virginia (137)
Washington D.C. (60)
Washington State (533)
West Virginia (3)
Wisconsin (51)
712,813 Results for "sysmex america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320
March 3, 2025
·
2 min read
Press Releases
Sysmex America Signs Agreement to Distribute and Service Sentinel Diagnostics SENTiFIT® in Canada
January 7, 2025
·
2 min read
BioMidwest
Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States
Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.
April 2, 2024
·
2 min read
BioMidwest
Sysmex America Becomes Exclusive Distributor of vermicon VIT® System in Canada, Latin America and Americas
Sysmex America, Inc., a leading diagnostic solutions company, has been named the exclusive distributor of vermicon identification technology System in Canada, Latin America and all the Americas.
December 14, 2023
·
2 min read
Business
Sysmex America Announces Dan Zortman as New CEO
July 10, 2024
·
2 min read
Business
Sysmex America Names Chris Cappella as Chief Financial Officer
Sysmex America, Inc. announced that Chris Cappella has joined the Company as Chief Financial Officer.
January 10, 2023
·
2 min read
Press Releases
Sysmex Inostics Achieves CAP Accreditation and ISO 15189 Certification, Enhancing Quality Standards in Diagnostic Excellence
December 11, 2024
·
2 min read
Inc. Magazine Names Xenco Medical one of the Best Companies to Work for in America
Inc. Magazine has named trailblazing life sciences company Xenco Medical one of the best companies to work for in America.
June 18, 2024
·
2 min read
Pharm Country
Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community
Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.
May 23, 2024
·
6 min read
Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay
Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies.
December 14, 2023
·
3 min read
1 of 71,282
Next